Global Bone Morphogenetic Protein (BMP) 2 Market Report, History and Forecast 2015-2026, Breakdown Data by Companies, Key Regions, Types and Application

Bone morphogenetic proteins (BMPs) are naturally occurring proteins found in the human body. This family of proteins is involved in a myriad of cellular responses. Certain BMPs are osteoinductive—one of the three main categories of bone grafts—and play an active role in bone formation and maintenance.
The classification of Bone Morphogenetic Protein (BMP) 2 includes sponge and gel types, and the proportion of sponge in 2016 is about 99%, and the proportion will be in decreasing trend from 2017 to 2022.
Bone Morphogenetic Protein (BMP) 2 is widely used in spinal fusion, trauma surgery, oral maxillofacial surgery and reconstructive. The most proportion of Bone Morphogenetic Protein (BMP) 2 is used in spinal fusion, and the consumption proportion is about 62% in 2016.
North America is the largest consumption place, with a consumption market share nearly 70% in 2016. Following North America, Europe is the second largest consumption place with the consumption market share of 20%.
Market competition is concentrated. Medtronic and Cellumed are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.

Market Analysis and Insights: Global Bone Morphogenetic Protein (BMP) 2 Market
The research report studies the Bone Morphogenetic Protein (BMP) 2 market using different methodologies and analyzes to provide accurate and in-depth information about the market. For a clearer understanding, it is divided into several parts to cover different aspects of the market. Each area is then elaborated to help the reader comprehend the growth potential of each region and its contribution to the global market. The researchers have used primary and secondary methodologies to collate the information in the report. They have also used the same data to generate the current market scenario. This report is aimed at guiding people towards an apprehensive, better, and clearer knowledge of the market.
The global Bone Morphogenetic Protein (BMP) 2 market size is projected to reach US$ 465.8 million by 2026, from US$ 411.2 million in 2020, at a CAGR of 2.1% during 2021-2026.

Global Bone Morphogenetic Protein (BMP) 2 Scope and Segment
The global Bone Morphogenetic Protein (BMP) 2 market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Bone Morphogenetic Protein (BMP) 2 market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2015-2026.

Segment by Type, the Bone Morphogenetic Protein (BMP) 2 market is segmented into
Sponge
Gel

Segment by Application, the Bone Morphogenetic Protein (BMP) 2 market is segmented into
Spinal Fusion
Trauma Surgery
Oral Maxillofacial Surgery
Reconstructive

Global Bone Morphogenetic Protein (BMP) 2 market: regional analysis, the major regions covered in the report are:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa

The report lists the major players in the regions and their respective market share on the basis of global revenue. It also explains their strategic moves in the past few years, investments in product innovation, and changes in leadership to stay ahead in the competition. This will give the reader an edge over others as a well-informed decision can be made looking at the holistic picture of the market.

The major vendors covered:
Medtronic
Cellumed

Frequently Asked Questions